Literature DB >> 25242159

Cardiovascular risk assessment in HIV-infected male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations.

Mateja Pirš1, Borut Jug2, Barbara Eržen2, Mišo Šabović2, Primož Karner3, Mario Poljak4, Janez Tomažič3.   

Abstract

INTRODUCTION: Traditional cardiovascular (CVD) risk assessment algorithms such as the Framingham Risk Score (FRS), Systematic Coronary Risk Evaluation (SCORE) and Prospective Cardiovascular Munster (PROCAM) were developed for general populations, their usefulness in HIV-infected population has not been confirmed. DAD algorithm was developed specifically for HIV-infected patients. The aim of our study was to evaluate the performance of risk assessment algorithms in HIV-infected population.
METHODS: A prospective cross-sectional national study that included 83 HIV-infected male patients from Slovenia below the age of 55 was performed. CVD risk was assessed using four algorithms, the presence of subclinical atherosclerosis was determined by measuring carotid intima-media thickness (CIMT); patients were followed up for 5 years.
RESULTS: High proportion of patients with low CVD risk according to FRS (61.9%) and PROCAM (81.0%) and only 7.1% according to SCORE had evidence of subclinical atherosclerosis. Only 7.1% of patients with low CVD risk according to DAD algorithm had evidence of subclinical atherosclerosis.
CONCLUSION: Our study has shown that SCORE and DAD algorithm were superior to FRS and PROCAM. In younger HIV-infected patients, even with moderate CVD risk, CIMT assessment should be employed in a complete clinical evaluation as a more aggressive prevention and treatment approach is warranted.

Entities:  

Mesh:

Year:  2014        PMID: 25242159     DOI: 10.15570/actaapa.2014.11

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  13 in total

Review 1.  Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.

Authors:  John Charles A Lacson; Revery P Barnes; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-04       Impact factor: 5.113

2.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

3.  Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus.

Authors:  Janine M Trevillyan; Carlee Moser; Judith S Currier; Tamer Sallam
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

4.  Cardiovascular Risk in HIV-Infected and Uninfected Postmenopausal Minority Women: Use of the Framingham Risk Score.

Authors:  Yamnia I Cortés; Nancy Reame; Cosmina Zeana; Haomiao Jia; David C Ferris; Elizabeth Shane; Michael T Yin
Journal:  J Womens Health (Larchmt)       Date:  2016-09-09       Impact factor: 2.681

Review 5.  Human immunodeficiency virus and acquired immunodeficiency syndrome: recent developments and their implications for pediatric surgeons.

Authors:  A Cooper
Journal:  Semin Pediatr Surg       Date:  1995-11       Impact factor: 2.754

6.  Effect of Probiotic Supplement on Cytokine Levels in HIV-Infected Individuals: A Preliminary Study.

Authors:  Katia Falasca; Jacopo Vecchiet; Claudio Ucciferri; Marta Di Nicola; Chiara D'Angelo; Marcella Reale
Journal:  Nutrients       Date:  2015-09-28       Impact factor: 5.717

Review 7.  Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection.

Authors:  Daniela Sofia Martins Pinto; Manuel Joaquim Lopes Vaz da Silva
Journal:  Curr Cardiol Rev       Date:  2018-03-14

Review 8.  HIV and ageing: improving quantity and quality of life.

Authors:  Keri N Althoff; Mikaela Smit; Peter Reiss; Amy C Justice
Journal:  Curr Opin HIV AIDS       Date:  2016-09       Impact factor: 4.283

9.  Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study.

Authors:  Steve Raoul Noumegni; Vicky Jocelyne Moor Ama; Felix K Assah; Jean Joel Bigna; Jobert Richie Nansseu; Jenny Arielle M Kameni; Jean-Claude Katte; Mesmin Y Dehayem; Andre Pascal Kengne; Eugene Sobngwi
Journal:  Trop Dis Travel Med Vaccines       Date:  2017-07-05

10.  Subclinical Carotid Atherosclerosis and Reduced DAD Score for Cardiovascular Risk Stratification in HIV-Positive Patients.

Authors:  Achilles Gustavo Silva; Rafael Vieira Paulo; Mario León Silva-Vergara
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.